NewsStock Market

Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance


Q3 2023 Insurance MCR Improved to 78.5% , bringing year-to-date MCR to 80.8% , and Insurance revenue grew 12% compared to Q3 2022 Company reports Q3 2023 Net Loss of $41.5 million and Adjusted EBITDA loss of $5.1 million Revised full-year 2023 guidance now reflects Insurance MCR of 81% – 82% and


Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button